Aileron Therapeutics (ALRN) Stock Chart & Stock Price History → The Sneaky IRS Tax Law that's Sweeping the U.S. (From Birch Gold) (Ad) Free ALRN Stock Alerts $3.91 -0.04 (-1.01%) (As of 12:39 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Aileron Therapeutics Stock Price Performance5 Day Performance+2.36%1 Month Performance-30.92%3 Month Performance-12.53%6 Month Performance+165.99%Year-To-Date Performance+28.26%1 Year Performance+186.45% Receive ALRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Birch GoldThe Sneaky IRS Tax Law that's Sweeping the U.S.In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.Request your info kit on gold now ALRN Stock Chart for Tuesday, May, 7, 2024 ALRN Chart by TradingView Aileron Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/06/2024$3.76$3.95+5.05%$4.01$3.8087,752 shs$66.64 million05/03/2024$3.82$3.76-1.57%$4.17$3.75142,724 shs$63.43 million05/02/2024$4.16$3.82-8.17%$4.30$3.76149,308 shs$64.44 million05/01/2024$4.55$4.16-8.57%$4.50$3.70483,852 shs$70.60 million04/30/2024$4.92$4.55-7.52%$5.00$4.47319,110 shs$77.21 million04/29/2024$5.00$4.92-1.60%$5.00$4.81159,751 shs$83.49 million Get the Latest News and Ratings for ALRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/26/2024$5.06$5.00-1.19%$5.19$4.9685,369 shs$84.85 million04/25/2024$4.93$5.06+2.64%$5.43$4.8480,550 shs$85.87 million04/24/2024$4.75$4.93+3.79%$4.93$4.65102,247 shs$83.66 million04/23/2024$4.75$4.75$4.99$4.5167,714 shs$80.61 million04/22/2024$4.74$4.75+0.21%$5.35$4.32109,866 shs$80.61 million04/19/2024$5.00$4.74-5.20%$5.03$4.6085,337 shs$23.18 million04/18/2024$4.25$5.00+17.65%$7.42$4.511.75 million shs$24.45 million04/17/2024$5.35$4.25-20.56%$5.27$4.1265,936 shs$20.78 million04/16/2024$5.93$5.35-9.78%$5.51$4.90200,528 shs$26.16 million04/15/2024$6.14$5.93-3.42%$6.17$5.5615,719 shs$29.00 million04/12/2024$5.72$5.86+2.45%$6.17$5.6412,992 shs$28.66 million04/11/2024$5.81$5.72-1.55%$5.99$5.6521,285 shs$27.94 million04/10/2024$5.89$5.81-1.36%$6.11$5.819,594 shs$28.38 million04/09/2024$6.29$5.89-6.36%$6.25$5.8118,931 shs$28.80 million04/08/2024$5.66$6.29+11.13%$6.66$5.51182,104 shs$30.76 million04/05/2024$5.90$5.66-4.07%$5.87$5.659,105 shs$27.68 million04/04/2024$5.86$5.90+0.68%$6.07$5.818,927 shs$28.85 million04/03/2024$6.04$5.86-2.98%$6.01$5.826,450 shs$28.66 million04/02/2024$5.86$6.04+3.07%$6.04$5.7121,645 shs$29.54 million04/01/2024$6.63$5.86-11.61%$6.84$5.7839,090 shs$28.66 million03/29/2024$6.50$6.63+2.00%$6.95$6.4422,881 shs$32.42 million03/28/2024$7.09$6.50-8.32%$6.95$6.4422,865 shs$31.79 million03/27/2024$5.78$7.09+22.66%$7.10$5.66159,359 shs$34.67 million03/26/2024$5.77$5.78+0.17%$6.11$5.6519,105 shs$28.26 million03/25/2024$6.20$5.77-6.94%$6.20$5.5845,743 shs$30.29 million03/22/2024$5.67$6.20+9.35%$6.20$5.6566,048 shs$30.32 million03/21/2024$5.50$5.67+3.09%$5.79$5.5125,094 shs$27.73 million03/20/2024$5.37$5.50+2.42%$5.60$5.3528,861 shs$26.90 million03/19/2024$5.41$5.37-0.74%$5.46$5.2723,266 shs$26.26 million03/18/2024$5.58$5.41-3.05%$5.67$5.3728,633 shs$26.46 million03/15/2024$5.53$5.58+0.90%$5.68$5.5015,138 shs$27.29 million03/14/2024$5.57$5.53-0.72%$5.75$5.5211,880 shs$27.04 million03/13/2024$5.25$5.57+6.10%$5.96$5.2124,191 shs$27.24 million03/12/2024$5.58$5.25-5.91%$5.75$5.0429,644 shs$25.67 millionThe best inflation-proof investment (Ad)The markets are CRAZY right now. Which is why thousands of investors are flocking into one little-known company. Click here for the full story03/11/2024$5.83$5.58-4.29%$5.90$5.5817,539 shs$27.26 million03/08/2024$5.66$5.82+2.83%$5.90$5.5139,859 shs$28.46 million03/07/2024$5.49$5.66+3.10%$5.66$5.4912,431 shs$27.68 million03/06/2024$5.55$5.49-1.08%$5.75$5.4021,609 shs$26.85 million03/05/2024$5.27$5.55+5.31%$5.76$5.1520,576 shs$27.14 million03/04/2024$5.00$5.27+5.40%$5.30$4.9522,835 shs$25.77 million03/01/2024$4.94$5.00+1.21%$5.15$4.7930,339 shs$24.45 million02/29/2024$4.72$4.94+4.66%$5.03$4.7735,026 shs$24.16 million02/28/2024$4.54$4.72+3.96%$5.69$4.6945,068 shs$23.08 million02/27/2024$4.68$4.54-2.99%$4.68$4.5224,046 shs$22.20 million02/26/2024$4.64$4.68+0.85%$4.75$4.5617,003 shs$22.86 million02/23/2024$4.75$4.67-1.68%$4.72$4.577,253 shs$22.84 million02/22/2024$4.66$4.75+1.93%$4.80$4.5215,863 shs$23.23 million02/21/2024$4.72$4.66-1.27%$4.78$4.528,988 shs$22.79 million02/20/2024$4.69$4.72+0.64%$4.78$4.5625,915 shs$23.08 million02/19/2024$4.69$4.69$4.69$4.4017,000 shs$22.93 million02/16/2024$4.68$4.68-0.11%$4.69$4.4017,073 shs$22.84 million02/15/2024$4.63$4.68+1.08%$4.69$4.488,636 shs$22.89 million02/14/2024$4.66$4.63-0.64%$4.68$4.4511,682 shs$22.64 million02/13/2024$4.34$4.66+7.37%$4.70$4.3432,411 shs$22.79 million02/12/2024$4.80$4.34-9.58%$4.77$4.2548,676 shs$21.22 million02/09/2024$4.78$4.79+0.21%$4.80$4.6713,956 shs$23.42 million02/08/2024$4.47$4.78+6.94%$4.80$4.5034,893 shs$23.37 million02/07/2024$4.33$4.47+3.23%$4.57$4.341,870 shs$21.86 million02/06/2024$4.67$4.33-7.36%$4.78$4.3025,789 shs$21.17 million Related Companies: Tempest Therapeutics Stock Price Chart Marinus Pharmaceuticals Stock Price Chart Connect Biopharma Stock Price Chart Spero Therapeutics Stock Price Chart BeyondSpring Stock Price Chart Corvus Pharmaceuticals Stock Price Chart LifeVantage Stock Price Chart Vaccitech Stock Price Chart Leap Therapeutics Stock Price Chart Barinthus Biotherapeutics Stock Price Chart Receive ALRN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALRN) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldThe best inflation-proof investment DTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aileron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.